Market by Phase Type, Service, Sponsor, and Country Outlook | Forecast 2022-2028
A report by Triton Market Research puts forth that the market for clinical trials support services in the Middle East and Africa would develop with a CAGR of 7.20% in the estimated duration 2022-2028.
Report scope can be customized per your requirements. Request For Customization
The countries evaluated in
this market include:
• Turkey
• Saudi Arabia
• The United Arab Emirates
• South Africa
• Rest of Middle East & Africa
South Africa accounted for the
largest share of the regional market in 2021. In the
Middle East and Africa, the population is growing at a significant rate, and
the demand for medication has also increased due to rare genetic diseases being
detected among the population. However, the major challenges faced by the
market are the cultural gap and lack of acknowledgment of the need to develop a
sustainable clinical research infrastructure.
South
Africa’s regulatory environment has changed drastically in recent years. The
national government is now more supportive of clinical research, and the
country itself offers several benefits. While infectious diseases receive the
most attention for developing therapies, non-communicable diseases also have a
significant impact. Thus, the nation is a promising market for conducting
clinical trials, which is expected to enhance the demand for support services
as well.
Turkey’s
pharmaceutical sector has set the goal of making the country the leader in
terms of clinical trials, in order to achieve global competitiveness. In 2020,
the nation ranked 26th, with 529 clinical trials. The vast majority of clinical
trials conducted here are in phases II and III, accounting for 93% of the total
number of industry-sponsored trials, with only 1 out of 100 being phase I. Because
of efficient R&D capabilities and experienced professionals, Turkey has
become an important clinical trials hub for contract research organizations. This
has bolstered the demand for support services in the country.
Patient
recruitment is a vital part of the clinical trial process. However, finding
patients and convincing them to participate in the trials is a challenging
task. Insufficient or untimely patient recruitment have significant
consequences, such as increasing the overall cost incurred. Therefore,
companies are offering various solutions for patient recruitment management.
Triton’s report assesses the
market according to service, phase type, and sponsor.
Here, the service segment comprises patient recruitment management, clinical
trial site management, administrative services, data management, regulatory
services, and other services.
The acclaimed players in the clinical
trials support services market include Labcorp Drug Development, WuXi AppTec,
KCR, Charles River Laboratories, Alcura, Worldwide Clinical Trials, and ICON
Plc.
Founded
in 1982, IQVIA is a leading organization providing technology solutions,
advanced analytics, and clinical research services to the life sciences
industry. It provides solutions under the R&D, commercialization,
technologies, healthcare, therapeutics areas, and other segments. IQVIA’s Orchestrated
Patient Engagement solution enables pharmaceutical companies to improve
communication and orchestration with the participating patients. Further, the
organization has a significant business presence in the Middle East and Africa.
IQVIA’s Orchestrated Customer Engagement (OCE) solution is widely used by other
companies like Biopharm, Kuwait Saudi Pharmaceuticals (KSP), Sudair Pharma, and
many more.
Key deliverables of the report:
·
Market
CAGR during the forecasting years 2022-2028
·
Detailed
data highlighting key insights, industry components, and market strategies
·
Comprehensive
information and estimation of the clinical trials support services market
revenue growth in the Middle East and Africa and its influence on the parent
market
·
In-depth
study of forthcoming trends in consumer behavioral patterns
·
A
meticulous analysis of the competitive landscape, vendor scorecard, and
Porter’s Five Forces Model
·
A
wide-ranging study of factors that will challenge the Middle East and Africa clinical
trials support services market’s growth during the upcoming years
Want
to get specific insights? Our team of analysts can customize this report based
on your preferences. Connect with us here.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE CLINICAL TRIALS SUPPORT SERVICES MARKET
2.2. KEY
INSIGHTS
2.2.1. KEY
PLAYERS’ PROMISING COLLABORATIONS
2.2.2. INCREASE
IN SCREENING TESTS
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
BUYING IMPACT ANALYSIS
2.4.1. PERFORMANCE
2.4.2. EASE
OF USE
2.4.3. SECURITY
2.4.4. COST
EFFECTIVENESS
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.8. KEY
MARKET STRATEGIES
2.8.1. ACQUISITIONS
2.8.2. PRODUCT
LAUNCHES
2.8.3. CONTRACTS
& AGREEMENTS
2.8.4. INVESTMENTS
& EXPANSIONS
2.9. MARKET
DRIVERS
2.9.1. NEED
TO OVERCOME THE BARRIERS IN CLINICAL TRIALS
2.9.2. RISE
IN TRIALS DUE TO INCREASED DISEASE INCIDENCE
2.10. MARKET
CHALLENGES
2.10.1. DELAYED
APPROVAL DUE TO STRINGENT REGULATORY FRAMEWORK
2.10.2. USE OF
OPEN-SOURCE SOFTWARE
2.11. MARKET
OPPORTUNITIES
2.11.1. INCREASING
DEMAND FOR VACCINES AND PHARMACEUTICALS
2.11.2. DATA
MANAGEMENT SERVICE EXPECTED TO WITNESS NOTABLE GROWTH
2.11.3. ACQUISITIONS
IN THE CLINICAL TRIALS SUPPORT SERVICES MARKET
3. MIDDLE
EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY PHASE TYPE
3.1. PHASE
I
3.2. PHASE
II
3.3. PHASE
III
3.4. PHASE
IV
4. MIDDLE
EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SERVICE
4.1. CLINICAL
TRIAL SITE MANAGEMENT
4.2. ADMINISTRATIVE
SERVICES
4.3. PATIENT
RECRUITMENT MANAGEMENT
4.4. REGULATORY
SERVICES
4.5. DATA
MANAGEMENT
4.6. OTHER
SERVICES
5. MIDDLE
EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET OUTLOOK – BY SPONSOR
5.1. PHARMACEUTICAL
& BIOPHARMACEUTICAL COMPANIES
5.2. MEDICAL
DEVICE COMPANIES
5.3. OTHER
SPONSORS
6. MIDDLE
EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET – COUNTRY OUTLOOK
6.1. UNITED
ARAB EMIRATES
6.2. SAUDI
ARABIA
6.3. TURKEY
6.4. SOUTH
AFRICA
6.5. REST
OF MIDDLE EAST & AFRICA
7. COMPETITIVE
LANDSCAPE
7.1. IQVIA
7.2. PAREXEL
7.3. ICON
PLC
7.4. SYNEOS
HEALTH
7.5. LABCORP
DRUG DEVELOPMENT
7.6. CLINIPACE
7.7. KCR
7.8. CHARLES
RIVER LABORATORIES
7.9. MEDPACE
7.10. ALCURA
7.11. PSI
CRO
7.12. WORLDWIDE
CLINICAL TRIALS
7.13. CTI
CLINICAL TRIAL AND CONSULTING SERVICES INC
7.14. WUXI
APPTEC
7.15. ADVANCED
CLINICAL
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.2. SOURCES
OF DATA
8.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST AND
AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN
$ MILLION)
TABLE 2: LIST OF
COLLABORATIONS
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF ACQUISITIONS
TABLE 5: LIST OF PRODUCT
LAUNCHES
TABLE 6: LIST OF CONTRACTS
& AGREEMENTS
TABLE 7: LIST OF INVESTMENTS
& BUSINESS EXPANSIONS
TABLE 8: LIST OF PANDEMIC
OUTBREAKS
TABLE 9: LIST OF OPEN-SOURCE
SOFTWARE
TABLE 10: LAUNCH OF MEDICAL
DRUGS
TABLE 11: PROMISING
ACQUISITIONS IN THE MARKET
TABLE 12: MIDDLE EAST AND
AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, 2022-2028 (IN $
MILLION)
TABLE 13: MIDDLE EAST AND
AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE TYPE, 2022-2028 (IN $
MILLION)
TABLE 14: MIDDLE EAST AND
AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, 2022-2028 (IN $
MILLION)
TABLE 15: MIDDLE EAST AND
AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2022-2028 (IN
$ MILLION)
FIGURE
1: KEY BUYING IMPACT ANALYSIS
FIGURE
2: MARKET ATTRACTIVENESS INDEX
FIGURE
3: INDUSTRY COMPONENTS
FIGURE
4: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE
TYPE, 2021 & 2028 (IN %)
FIGURE
5: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I,
2022-2028 (IN $ MILLION)
FIGURE
6: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II,
2022-2028 (IN $ MILLION)
FIGURE
7: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE
III, 2022-2028 (IN $ MILLION)
FIGURE
8: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV,
2022-2028 (IN $ MILLION)
FIGURE
9: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE,
2021 & 2028 (IN %)
FIGURE
10: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL
TRIAL SITE MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE
11: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY
ADMINISTRATIVE SERVICES, 2022-2028 (IN $ MILLION)
FIGURE
12: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT
RECRUITMENT MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE
13: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY REGULATORY
SERVICES, 2022-2028 (IN $ MILLION)
FIGURE
14: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA
MANAGEMENT, 2022-2028 (IN $ MILLION)
FIGURE
15: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER
SERVICES, 2022-2028 (IN $ MILLION)
FIGURE
16: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR,
2021 & 2028 (IN %)
FIGURE
17: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY
PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE
18: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL
DEVICE COMPANIES, 2022-2028 (IN $ MILLION)
FIGURE
19: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER
SPONSORS, 2022-2028 (IN $ MILLION)
FIGURE
20: MIDDLE EAST AND AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY
OUTLOOK, 2021 & 2028 (IN %)
FIGURE
21: UNITED ARAB EMIRATES CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN
$ MILLION)
FIGURE
22: SAUDI ARABIA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
23: TURKEY CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $ MILLION)
FIGURE
24: SOUTH AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET 2022-2028 (IN $
MILLION)
FIGURE
25: REST OF MIDDLE EAST & AFRICA CLINICAL TRIALS SUPPORT SERVICES MARKET
2022-2028 (IN $ MILLION)